Octostim (Desmopressin Acetate)

Desmopressin Acetate, the active ingredient in Octostim, is a synthetic analog of the natural hormone vasopressin presented as a tablet for oral use. It is employed in the management of central diabetes insipidus, certain bleeding disorders, and nocturnal enuresis in children and adults. GNH USA supplies Octostim as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Octostim is a synthetic vasopressin analog that acts on the antidiuretic hormone pathway to reduce urine output and enhance coagulation factor release. - Central Diabetes Insipidus: Helps reduce excessive thirst and urine volume. - Nocturnal Enuresis: Decreases nighttime bladder emptying in children and adolescents. - Mild Hemophilia A and von Willebrand Disease: Raises plasma levels of factor VIII and von Willebrand factor to improve clotting. - Pre‑surgical Surgical Preparation: Used to control bleeding before minor procedures. - Management of Hyponatremia Risk: Allows careful water balance management. - Support for renal concentrating ability in certain renal disorders of the kidney .

Desmopressin acetate may elicit a range of adverse reactions, from mild to severe, depending on individual sensitivity and dosing.

Common Side Effects: - Headache  - Nasal congestion  - Mild nausea - Flushing  - Hyponatraemia  - Nasal dryness 

Serious or Rare Side Effects: - Seizure 

t           -        Severe hyponatraemia causing brain edema  -       Throm   t             

Octof    g    t  d   ewline  ewline \n   ewline  he   ewline \

...